Provided is a fat or oil having a high diacylglycerol content and rich in -linolenic acid, in which crystallization at low temperature is suppressed, and which hardly causes white turbidity or deposition. Specifically, provided is a fat or oil composition, which satisfies the following (1) to (4): (1) a content of -linolenic acid in constituent fatty acids of a fat or oil is 40 mass % or more; (2) a total content of a saturated fatty acid having 16 carbon atoms and a saturated fatty acid having 18 carbon atoms in the constituent fatty acids of the fat or oil is 6 mass % or less, and a content of the saturated fatty acid having 18 carbon atoms in the constituent fatty acids of the fat or oil is less than 3 mass %; (3) a content mass ratio of the saturated fatty acid having 16 carbon atoms (P) to the saturated fatty acid having 18 carbon atoms (S) , [(P)/(S)], in the constituent fatty acids of the fat or oil is 0.1 or more and less than 3.5; and (4) a content of diacylglycerols is 25 mass % or more.

The present invention relates to compositions comprising DHA, EPA, LA and GLA. The compositions may further comprise other omega-3 PUFAs, MUFAs, SFAs, gamma tocopherol, Vitamin A and Vitamin E. The compositions are useful for treating neurologic disorders. The compositions are administered chronically for the prevention and/or treatment of multiple sclerosis (MS) and other degenerative diseases.

The present invention relates to compositions comprising DHA, EPA, LA and GLA. The compositions may further comprise other omega-3 PUFAs, MUFAs, SFAs, gamma tocopherol, Vitamin A and Vitamin E. The compositions are useful for treating neurologic disorders. The compositions are administered chronically for the prevention and/or treatment of multiple sclerosis (MS) and other degenerative diseases.

Liquid food product suitable to manage the ketogenic diet, which comprises at least lipids, carbohydrates, fibers, proteins and water.

Liquid food product suitable to manage the ketogenic diet, which comprises at least lipids, carbohydrates, fibers, proteins and water.

The present invention provides dietary formulations comprising polyunsaturated fatty acids and vitamin E. The present invention further provides methods of treating various conditions, generally involving administering to an individual in need thereof an effective amount of a subject dietary formulation.

The present invention provides dietary formulations comprising polyunsaturated fatty acids and vitamin E. The present invention further provides methods of treating various conditions, generally involving administering to an individual in need thereof an effective amount of a subject dietary formulation.

The present invention relates to animal meat enriched with Omega-3 polyunsaturated fatty acids for use in increasing the Omega-3 polyunsaturated fatty acids levels in human plasma by dietary administration of the animal meat enriched with Omega-3 polyunsaturated fatty acids to a subject. Also disclosed is a method of increasing the Omega-3 polyunsaturated fatty acids levels in human plasma comprising dietary administration of the animal meat enriched with Omega-3 polyunsaturated fatty acids to the subject.

The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo--linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo--linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo--linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.

The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo--linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo--linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo--linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.